Korea Pharmaceutical and Bio-Pharma Manufacturers Association to Host 'AI Pharma Korea Conference 2026'
Published
The Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA) will host the 'AI Pharma Korea Conference 2026' to discuss the future of AI-driven drug discovery. This event will serve as a venue for domestic and international researchers and industry experts to gather and share the latest technologies and achievements.
At this conference, successful cases of AI-utilized drug development will be presented. Experts will share specific information on how AI technology can shorten drug development timelines and reduce costs.
Furthermore, the event aims to strengthen industry-academia cooperation and expand research networks. The goal is to enhance the competitiveness of the Korean pharmaceutical industry by providing opportunities for researchers from universities and companies to collaborate with one another.
Keynote speeches from overseas experts, including those from the UK, are also prepared, offering a great opportunity to grasp global technology trends. Through this conference, it is expected that Korea's AI-based drug discovery technology will take a step forward.
Sources: MEDI:GATE NEWS
More South Korea news
- Digital TVET master's program launches in South Korea
- Gyeongbuk health group donates 100 boxes of grapes to children
- US Big Tech Pursues Multi-Trillion Won Investments in South Korean Data Centers Amid Uncertainty
- KB Insurance to Hold Open Recruitment for New Employees in Second Half of 2026
- Kolmar Korea Wins CES Beauty Tech Best Innovation Award for Second Straight Year, Setting World First
- China Closes In on Korea's Core LNG Carrier Market, Expanding from Mega-Vessels to Equipment
- China's Rapid Technological Development: South Korea Must Change Its Regulations and Labor System
- Ambassador Michelle Steel: American Companies Operating in Korea Should Compete in a Fair Environment